Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors

被引:27
作者
Gonzalez, MM [1 ]
Carlberg, C [1 ]
机构
[1] Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland
关键词
D O I
10.1074/jbc.M200205200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear receptors (NRs) and POU domain factors form two important transcription factor families for which several levels of functional interference have been described. In this study, the adopted orphan receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR) were found to perform direct protein-protein interactions with Pit-1, a representative POU domain factor. The ligand-dependent interaction profile of Pit-1 with CAR, PXR, and the vitamin D receptor in solution was shown to be that of a corepressor. In the absence of receptor agonist Pit-1 inhibited the complex formation of NRs with the retinoid X receptor on DNA. Also in living cells, Pit-1 and Oct-1, another POU domain factor, behaved like corepressors of NR signaling, and Pit-1-mediated repression was found to involve histone deacetylases. Conversely vitamin D receptor, CAR, and PXR were shown to act as repressors of Pit-1 signaling in different cell lines (MCF-7, HaCaT, and GH4C1). This repression was found to be independent of histone deacetylases and seems to be based on a competition of NRs with coactivator and corepressor proteins for overlaying interaction interfaces on the surface of Pit-1. Taken together this study suggests that cross-repression should occur in all tissues in which POU domain factors and non-liganded NRs meet each other.
引用
收藏
页码:18501 / 18509
页数:9
相关论文
共 42 条
[1]   Nuclear receptors in cell life and death [J].
Altucci, L ;
Gronemeyer, H .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (10) :460-468
[2]  
Auwerx J, 1999, CELL, V97, P161
[3]   A NEW ORPHAN MEMBER OF THE NUCLEAR HORMONE-RECEPTOR SUPERFAMILY THAT INTERACTS WITH A SUBSET OF RETINOIC ACID RESPONSE ELEMENTS [J].
BAES, M ;
GULICK, T ;
CHOI, HS ;
MARTINOLI, MG ;
SIMHA, D ;
MOORE, DD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1544-1552
[4]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[5]   Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213
[6]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[7]   Co-repressors 2000 [J].
Burke, LJ ;
Baniahmad, A .
FASEB JOURNAL, 2000, 14 (13) :1876-1888
[8]   Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: Role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1) [J].
Castillo, AI ;
Jimenez-Lara, AM ;
Tolon, RM ;
Aranda, A .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (07) :1141-1154
[9]   Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR [J].
Choi, HS ;
Chung, MR ;
Tzameli, I ;
Simha, D ;
Lee, YK ;
Seol, W ;
Moore, DD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23565-23571
[10]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356